Group Meetings
Group-wide meetings of the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) occur twice a year and are open to researchers affiliated with member institutions, patient advocates who are members of ECOG-ACRIN’s various scientific committees, industry representatives, and invited individuals from external (non-member) organizations. Group meetings are closed to the public.
Purpose
- Present the latest in basic, clinical, and translational research by Group leaders in the areas of cancer prevention, imaging, diagnosis, and treatment
- Provide a forum for academic inquiry among physicians, clinical research professionals, patient advocates, and others
- Host education sessions on engaging patients and the public in the clinical research process
- Reinforce compliance with Group policies and procedures
- Offer non-CME training and education workshops for research professionals
Virtual Fall 2020 Group Meeting
Tuesday, October 20 – Friday, October 23
View the session schedule
Visit the group meeting website
Access the Fall 2020 Group Meeting App on your desktop (registered attendees)
Please note: The Virtual Fall 2020 Group Meeting was open to rostered and non-rostered staff from ECOG-ACRIN member institutions, ECOG-ACRIN advocates, ECOG-ACRIN staff, NCI/NIH employees, and invited guests only. We regret we were unable to accommodate non-members or industry attendees this fall.
Questions? Email us
Interested in becoming an Industry sponsor or exhibitor for a future meeting?
Request a Group Meeting Prospectus from Christina Chink via phone at 215.789.3639 or send an email.
Spring 2021: Baltimore, Marriott Waterfront, Apr. 28-30 (W-F)
Fall 2021: Fort Lauderdale, Marriott Harbor Beach Resort and Spa, Oct. 20-22 (W-F)
Spring 2022: Chicago, Marriott Downtown Magnificent Mile, May 4-6 (W-F)
Fall 2022: Washington DC, Renaissance DC Downtown, Oct. 26-28 (W-F)
Spring 2023: Chicago, Marriott Downtown Magnificent Mile, May 3-5 (W-F)
Fall 2023: Washington DC, Renaissance DC Downtown, Oct. 25-27 (W-F)
Questions?
© 2020 ECOG-ACRIN Cancer Research Group. All rights reserved. | Disclaimer